PTHS · Pelthos Therapeutics Inc.
AI read · Neutral
The AI's read
D-Fi could give Pelthos another medicine program. The filing gives no trial results or estimate of its value. Castle Creek owners would receive 5.2 million Pelthos shares. They could also receive up to 5.8 million more shares if D-Fi gets FDA approval by March 31, 2036. Pelthos could also owe up to $300 million if D-Fi reaches specified goals. The deal depends on conditions, and the filing does not show whether D-Fi's value matches those commitments.